Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Cohort Analysis
100%
Systemic Lupus Erythematosus
69%
Hazard Ratio
34%
Rheumatoid Arthritis
33%
Inflammatory Arthritis
33%
Comorbidity
26%
Diseases
25%
Systemic Scleroderma
25%
Cohort Effect
22%
Sjoegren Syndrome
19%
Dermatomyositis
19%
Polymyositis
19%
Autoimmunity
18%
Myasthenia gravis
18%
Autoimmune Rheumatic Disease
17%
Rheumatic Disease
17%
Proportional Hazards Model
15%
Autoimmune Disease
15%
Pneumocystis Jirovecii
11%
Kidney Transplantation
11%
Acute Pancreatitis
11%
Influenza
11%
Obstructive Sleep Apnea
11%
Tuberculosis
11%
Pneumonia
11%
Steroid
11%
Survival Rate
10%
Popliteal Cyst
8%
Prevalence
8%
Musculoskeletal System
8%
Neurodevelopmental Disorder
7%
Total Knee Arthroplasty
7%
Hip Replacement
7%
Kidney Graft
7%
Hip Fracture
7%
Atopic Dermatitis
7%
Hydroxychloroquine
7%
Ankylosing Spondylitis
6%
Lung Tuberculosis
6%
Cancer
6%
End Stage Renal Disease
6%
Brain Ischemia
6%
Congestive Heart Failure
6%
Osteoarthritis
6%
Rheumatology
6%
Treatment Response
6%
Knee Osteoarthritis
6%
Malignant Neoplasm
6%
Survival Analysis
6%
Chronic Obstructive Pulmonary Disease
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
57%
Systemic Lupus Erythematosus
43%
Rheumatoid Arthritis
36%
Inflammatory Arthritis
36%
Sjoegren Syndrome
24%
Rheumatic Disease
22%
Autoimmune Disease
22%
Syndrome
21%
Systemic Sclerosis
20%
Diseases
19%
Influenza
17%
Peptide
14%
Dermatomyositis
13%
Polymyositis
13%
Autoantibodies
13%
Psoriasis
12%
Sleep Disordered Breathing
11%
Dipeptidyl Peptidase IV Inhibitor
11%
Osteoarthritis
11%
Hydroxychloroquine
11%
Maturity Onset Diabetes of the Young
11%
Comorbidity
10%
Hip Fracture
7%
Steroids
7%
Congestive Heart Failure
6%
Thyroiditis
6%
4 Hydroxynonenal
5%
Malonaldehyde
5%
Hepatitis C
5%
Hepatitis B Virus
5%
Proton Pump Inhibitor
5%
Jaw Osteonecrosis
5%
Lesinurad
5%
Trypsin Inhibitor
5%
Virus Hepatitis
5%
Bisoprolol
5%
Pneumocystis Jiroveci
5%
Histamine H1 Receptor Antagonist
5%
Liver Cell Carcinoma
5%
Carvedilol
5%
Tumor Necrosis
5%
Subarachnoid Hemorrhage
5%
Vaccination
5%
Antiphospholipid Syndrome
5%
Biocompatibility
5%
Morbidity
5%
Metal Nanoparticle
5%
Chronic Obstructive Lung Disease
5%
Immunoglobulin G
5%
Thiazolidinedione
5%
Immunology and Microbiology
Inflammatory Arthritis
55%
Systemic Lupus Erythematosus
50%
Peptides
29%
Autoantibodies
27%
Sjögren's Syndrome
18%
Isotype
17%
Infectious Disease
15%
Infection
15%
Comorbidity
15%
Immunoglobulin M
14%
Autoimmune Disease
13%
Systemic Scleroderma
12%
Immunoglobulin A
12%
Autoimmune Rheumatic Disease
11%
Epidemiology
11%
Cohort Effect
11%
Parkinson's Disease
11%
Heavy Chain
6%
Lupus Erythematosus
6%
Oxidative Stress
6%
Autoimmunity
6%
Prevalence
6%
Tumor Necrosis Factor Alpha
6%
Myasthenia gravis
5%
Nephritis
5%
Ankylosing Spondylitis
5%
Dermatomyositis
5%
Polymyositis
5%
Inter-Alpha-Trypsin Inhibitor
5%
Idiopathic Thrombocytopenic Purpura
5%
Viral Disease
5%
Decision Trees
5%
Herpes Simplex Virus
5%
Interferon Type I
5%
C1-Inhibitor
5%
Interleukin 23
5%
Rituximab
5%
Cell Membrane
5%
Wellbeing
5%
Blood Brain Barrier
5%
Mitochondrion
5%
Oxidation Reduction Potential
5%
Decision Making
5%
Acute Pancreatitis
5%
Hepatitis C
5%
Dioxygen
5%
Hydroxychloroquine
5%
Rheumatic Disease
5%
Oophoritis
5%
Influenza
5%
